Neuro-Innovators, Inc.

Healing Brains w/ Neuroplastic Medicine™ Engineer compound drugs engaging multiple Mechanisms of Plasticity to enhance healing, rewiring of human brains

  • Stage Product In Development
  • Industry Biotechnology
  • Location Pittsburgh, PA, USA
  • Currency USD
  • Founded December 2021
  • Employees 9
  • Incorporation Type C-corp
  • Website neuro-innovators.com

Company Summary

Neuro-Innovators is a first mover, clinical stage drug company using polypharmacology to enhance neuroplasticity and heal brains. Combining FDA approved drugs makes us eligible for the FDA's 505(b)(2) pathway. This allows for lower development costs, improved approval risk, and faster time to market. Initial indication - stroke survivors suffering from chronic motor disabilities 6+ months after a stroke... a $20 billion unmet need.

Team

  • Howison Schroeder
    CEO

    Business Operations and Development, Banking and Economics, Medical Device Commercialization, Neurological Diagnostics

  • Aura Kullmann, Ph.D.
    Clinical Trial Manager

    Neurobiology and Biophysics, Novel Target Identification and Validation, Clinical Trial Design and Execution, Regulatory Changes and Compliance

  • Ian Reynolds
    Neuro-pharmacologist

    Neuropharmacology, Neuro Drug Discovery for Pharma Majors and Start-ups, Licensing, Scientific Leadership and Entrepreneurship, Education & Publication

  • Peter Doyle
    Co-Founder & Director & Chief Medical Officer

    Internal Medicine, Acute Care, Concussion and Sports Medicine, Medical Research & Education

  • Mark Cochran, PhD
    COO & Director

    PhD Microbiologist. Ran Business Development for Bayer, a partner with NeuroVentures a venture capital firm focused on the neurosciences.

Advisors

  • Mark Cochran
    George Wittenberg, MD, PhD - Prof. of Neurology, Bioengineering, Physical Medicine, & Rehabilitation Univ. of Pittsburgh Medical School Medical Director, Rehab Neural Engineering Labs
    Unconfirmed
    John Lazo, PhD - Professor of Pharmacology & Chemistry, CSO KeViRx, Inc
    Unconfirmed
  • Ken Phelps - President, Co-founder Camargo Pharmaceutical Services
    Unconfirmed

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free